Scl binds to primed enhancers in mesoderm to regulate hematopoietic and cardiac fate divergence
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Scl/Tal1 confers hemogenic competence and prevents ectopic cardiomyogenesis in embryonic endothelium by unknown mechanisms. We discovered that Scl binds to hematopoietic and cardiac enhancers that become epigenetically primed in multipotent cardiovascular mesoderm, to regulate the divergence of hematopoietic and cardiac lineages. Scl does not act as a pioneer factor but rather exploits a pre‐established epigenetic landscape. As the blood lineage emerges, Scl binding and active epigenetic modifications are sustained in hematopoietic enhancers, whereas cardiac enhancers are decommissioned by removal of active epigenetic marks. Our data suggest that, rather than recruiting corepressors to enhancers, Scl prevents ectopic cardiogenesis by occupying enhancers that cardiac factors, such as Gata4 and Hand1, use for gene activation. Although hematopoietic Gata factors bind with Scl to both activated and repressed genes, they are dispensable for cardiac repression, but necessary for activating genes that enable hematopoietic stem/progenitor cell development. These results suggest that a unique subset of enhancers in lineage‐specific genes that are accessible for regulators of opposing fates during the time of the fate decision provide a platform where the divergence of mutually exclusive fates is orchestrated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GREAT improves functional interpretation of cis-regulatory regions
McLean, C. Y., Bristor, D., Hiller, M., Clarke, S. L., Schaar, B. T., Lowe, C. B., Wenger, A. M., & Bejerano, G. (2010) · Nature Biotechnology · doi:10.1038/nbt.1630 · Cited by 4,502
Histone modifications at human enhancers reflect global cell-type-specific gene expression
Heintzman, N. D., Hon, G. C., Hawkins, R. D., Kheradpour, P., Stark, A., Harp, L. F., Ye, Z., Lee, L. K., Stuart, R. K., Ching, C. W., et al. (2009) · Nature · doi:10.1038/nature07829 · Cited by 2,533 · cited 1×
“Our finding that Scl directs mesoderm diversification via enhancers is concordant with the data that transcription factor binding at enhancers is a key determinant of tissue-specific gene expression (Heintzman et al , 2009; Visel et al , 2009; Xu et al , 2012).”
Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors
Ieda, M., Fu, J.-D., Delgado-Olguin, P., Vedantham, V., Hayashi, Y., Bruneau, B. G., & Srivastava, D. (2010) · Cell · doi:10.1016/j.cell.2010.07.002 · Cited by 2,454 · cited 1×
“…factors can reprogram fibroblasts (or other cells) into a variety of cell types that closely resemble pluripotent cells, neurons, pancreatic beta cells, cardiomyocytes or hematopoietic cells (Takahashi & Yamanaka, 2006; Ieda et al , 2010; Huang et al , 2011; Kim et al , 2011; Pereira et al , 2013).”
ChIP-seq accurately predicts tissue-specific activity of enhancers
Visel, A., Blow, M. J., Li, Z., Zhang, T., Akiyama, J. A., Holt, A., Plajzer-Frick, I., Shoukry, M., Wright, C., Chen, F., et al. (2009) · Nature · doi:10.1038/nature07730 · Cited by 1,639 · cited 2×
“…correlated Scl mesodermal binding sites with published datasets for cardiac enhancers, including the Vista Enhancer database that contains in vivo experimentally verified enhancers (Visel et al , 2007) and ChIP-seq analysis for co-activator p300, a marker of enhancers (Visel et al , 2009), in E11.”
VISTA Enhancer Browser—a database of tissue-specific human enhancers
Visel, A., Minovitsky, S., Dubchak, I., & Pennacchio, L. A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl822 · Cited by 1,080
Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors
Huang, P., He, Z., Ji, S., Sun, H., Xiang, D., Liu, C., Hu, Y., Wang, X., & Hui, L. (2011) · Nature · doi:10.1038/nature10116 · Cited by 864 · cited 1×
“…factors can reprogram fibroblasts (or other cells) into a variety of cell types that closely resemble pluripotent cells, neurons, pancreatic beta cells, cardiomyocytes or hematopoietic cells (Takahashi & Yamanaka, 2006; Ieda et al , 2010; Huang et al , 2011; Kim et al , 2011; Pereira et al , 2013).”
Wilson, N. K., Foster, S. D., Wang, X., Knezevic, K., Schütte, J., Kaimakis, P., Chilarska, P. M., Kinston, S., Ouwehand, W. H., Dzierzak, E., et al. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.07.016 · Cited by 728
Cbfa2 is required for the formation of intra-aortic hematopoietic clusters
North, T., Gu, T.-L., Stacy, T., Wang, Q., Howard, L., Binder, M., Marín-Padilla, M., & Speck, N. A. (1999) · Development · doi:10.1242/dev.126.11.2563 · Cited by 662
Intragenic Enhancers Act as Alternative Promoters
Kowalczyk, M. S., Hughes, J. R., Garrick, D., Lynch, M. D., Sharpe, J. A., Sloane-Stanley, J. A., McGowan, S. J., De Gobbi, M., Hosseini, M., Vernimmen, D., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.12.021 · Cited by 267
Induction of a hemogenic program in mouse fibroblasts
Pereira, C.-F., Chang, B., Qiu, J., Niu, X., Papatsenko, D., Hendry, C. E., Clark, N. R., Nomura-Kitabayashi, A., Kovacic, J. C., Ma’ayan, A., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.05.024 · Cited by 216 · cited 1×
“…factors can reprogram fibroblasts (or other cells) into a variety of cell types that closely resemble pluripotent cells, neurons, pancreatic beta cells, cardiomyocytes or hematopoietic cells (Takahashi & Yamanaka, 2006; Ieda et al , 2010; Huang et al , 2011; Kim et al , 2011; Pereira et al , 2013).”
Cited by
Resolving early mesoderm diversification through single-cell expression profiling
Scialdone, A., Tanaka, Y., Jawaid, W., Moignard, V., Wilson, N. K., Macaulay, I. C., Marioni, J. C., & Göttgens, B. (2016) · Nature · doi:10.1038/nature18633 · Cited by 293
Using single-cell genomics to understand developmental processes and cell fate decisions
Griffiths, J. A., Scialdone, A., & Marioni, J. C. (2018) · Molecular Systems Biology · doi:10.15252/msb.20178046 · Cited by 250
“Under a binary decision model, Tal1 / cells would necessarily differentiate to a cardiac lineage in the absence of this key transcription factor, as supported by in vitro studies (Org et al, 2015).”
ResultSCL/TAL1: a multifaceted regulator from blood development to disease
Porcher, C., Chagraoui, H., & Kristiansen, M. S. (2017) · Blood · doi:10.1182/blood-2016-12-754051 · Cited by 135
Dogan, N., Wu, W., Morrissey, C. S., Chen, K.-B., Stonestrom, A., Long, M., Keller, C. A., Cheng, Y., Jain, D., Visel, A., et al. (2015) · Epigenetics & Chromatin · doi:10.1186/s13072-015-0009-5 · Cited by 114
Zacher, B., Michel, M., Schwalb, B., Cramer, P., Tresch, A., & Gagneur, J. (2017) · PLOS ONE · doi:10.1371/journal.pone.0169249 · Cited by 91
“[48] Org, T.”
Background
Metadata
- Authors
- Org, T., Duan, D., Ferrari, R., Montel‐Hagen, A., Van Handel, B., Kerényi, M. A., Sasidharan, R., Rubbi, L., Fujiwara, Y., Pellegrini, M., Orkin, S. H., Kurdistani, S. K., & Mikkola, H. K.
- Venue
- The EMBO Journal
- Published
- 2015-01-07
- Volume
- 34
- Issue
- 6
- Pages
- 759-777
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W2067814074
- Cited by
- 73
- References
- 12
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Scl binds to primed enhancers in mesoderm to regulate hematopoietic and cardiac fate divergence. https://app.cochat.ai/papers/10.15252/embj.201490542
- The paper
- Org, T., Duan, D., Ferrari, R., Montel‐Hagen, A., Van Handel, B., Kerényi, M. A., Sasidharan, R., Rubbi, L., Fujiwara, Y., Pellegrini, M., Orkin, S. H., Kurdistani, S. K., & Mikkola, H. K. (2015). Scl binds to primed enhancers in mesoderm to regulate hematopoietic and cardiac fate divergence. The EMBO Journal. https://doi.org/10.15252/embj.201490542
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.